Stefano Giardino
Overview
Explore the profile of Stefano Giardino including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
210
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ferrando G, Bagnasco F, Pierri F, Pestarino S, DellOrso G, Giardino S, et al.
Front Immunol
. 2024 Nov;
15:1492367.
PMID: 39524439
Background: Epstein-Barr virus (EBV) reactivation represents a frequent condition after allogeneic hematopoietic stem cell transplantation (allo-HCT) and can cause the development of a severe complication: post-transplant lymphoproliferative disease (PTLD). This...
2.
Ferrando G, Bagnasco F, Giardino S, Pierri F, Pestarino S, Di Marco E, et al.
Diagnostics (Basel)
. 2024 Nov;
14(21).
PMID: 39518428
Background: CMV reactivation represents a frequent complication after HSCT. The aim of this study was to describe the incidence of CMV reactivation in a pediatric HSCT cohort and analyze the...
3.
Naviglio S, Cicalese M, Rivers E, Ferrua F, Bonfim C, Cenciarelli S, et al.
Blood
. 2024 Jul;
144(16):1699-1704.
PMID: 39046813
Up to 70% of patients with Wiskott-Aldrich syndrome (WAS) develop autoimmune and inflammatory manifestations. Dysregulation of interleukin 1 (IL-1) may be involved in their pathogenesis, yet there is little evidence...
4.
Lum S, Albert M, Gilbert P, Sirait T, Algeri M, Muratori R, et al.
Blood
. 2024 Apr;
144(5):565-580.
PMID: 38669631
HLA-mismatched transplants with either in vitro depletion of CD3+ T-cell receptor (TCR)αβ/CD19 (TCRαβ) cells or in vivo T-cell depletion using posttransplant cyclophosphamide (PTCY) have been increasingly used for patients with...
5.
Giardino S, Eikema D, Piepenbroek B, Algeri M, Ayas M, Faraci M, et al.
Am J Hematol
. 2024 Mar;
99(6):1066-1076.
PMID: 38497679
Haploidentical stem cell transplantation (haplo-SCT) represents the main alternative for children with inherited bone marrow failure syndrome (I-BMF) lacking a matched donor. This retrospective study, conducted on behalf of the...
6.
Caballero-Oteyza A, Crisponi L, Peng X, Yauy K, Volpi S, Giardino S, et al.
J Allergy Clin Immunol
. 2023 Dec;
153(3):831-843.
PMID: 38040041
Background: To date, no publicly accessible platform has captured and synthesized all of the layered dimensions of genotypic, phenotypic, and mechanistic information published in the field of inborn errors of...
7.
Robin C, Cordonnier C, Tridello G, Knelange N, Xhaard A, Chantepie S, et al.
Transplant Cell Ther
. 2023 Nov;
30(2):235.e1-235.e10.
PMID: 38007092
Pneumocystis pneumonia (PCP) is a life-threatening complication after allogeneic hematopoietic cell transplantation (allo-HCT). However, allo-HCT procedures have evolved toward older patients, unrelated donors, and reduced-intensity conditioning, possibly modifying the risks....
8.
Giardino S, Pierri F, Faraci M
Br J Haematol
. 2023 Aug;
203(2):158-160.
PMID: 37583352
Up-front allogeneic haematopoietic stem cell transplantation (allo-HSCT) after a reduced intensity conditioning regimen is the standard treatment in children with acquired severe aplastic anaemia (aSAA) and inherited bone marrow failure...
9.
Endoscopic Approach in the Diagnosis of Gastrointestinal Acute Graft Versus Host Disease in Children
Faraci M, Giardino S, Madeo A, Coccia C, Arrigo S, Pierri F, et al.
JPGN Rep
. 2023 May;
3(1):e163.
PMID: 37168750
Methods: This was a retrospective study conducted, at the IRCSS Istituto G. Gaslini in Genova, Italy, in 26 children undergoing upper or lower GI endoscopy after allogeneic hematopoietic stem cell...
10.
Eichholz T, Doring M, Giardino S, Gruhn B, Seitz C, Flaadt T, et al.
Front Oncol
. 2023 Mar;
13:1064190.
PMID: 36895486
Background: Prognosis of children with primary disseminated or metastatic relapsed sarcomas remains dismal despite intensification of conventional therapies including high-dose chemotherapy. Since haploidentical hematopoietic stem cell transplantation (haplo-HSCT) is effective...